News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,092 Results
Type
Article (2466)
Company Profile (2)
Press Release (34624)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (18500)
Career Advice (5)
Deals (2561)
Drug Delivery (3)
Drug Development (4891)
FDA (569)
Job Trends (895)
News (25268)
Policy (1282)
Tag
Academia (82)
Accelerated approval (1)
Adcomms (4)
Allergies (6)
Alliances (7490)
ALS (15)
Alzheimer's disease (122)
Antibody-drug conjugate (ADC) (50)
Approvals (595)
Artificial intelligence (53)
Autoimmune disease (21)
Bankruptcy (11)
Best Places to Work (824)
Biosimilars (3)
Biotechnology (5)
Bladder cancer (3)
Brain cancer (6)
Breast cancer (37)
Cancer (270)
Cardiovascular disease (41)
Career advice (5)
CAR-T (18)
Cell therapy (50)
Cervical cancer (1)
Clinical research (4306)
Collaboration (427)
Compensation (20)
Complete response letters (4)
COVID-19 (153)
CRISPR (6)
C-suite (28)
Cystic fibrosis (8)
Data (298)
Depression (8)
Diabetes (25)
Diagnostics (147)
Diversity (1)
Drug discovery (35)
Drug pricing (1)
Drug shortages (1)
Duchenne muscular dystrophy (14)
Earnings (9673)
Editorial (1)
Events (2544)
Executive appointments (29)
FDA (749)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (2)
Funding (77)
Gene editing (15)
Generative AI (6)
Gene therapy (43)
GLP-1 (90)
Government (105)
Guidances (92)
Healthcare (713)
HIV (3)
Huntington's disease (2)
IgA nephropathy (5)
Immunology and inflammation (29)
Immuno-oncology (7)
Indications (8)
Infectious disease (168)
Inflammatory bowel disease (18)
Influenza (7)
Intellectual property (29)
IPO (1102)
Job creations (133)
Job search strategy (5)
JPM (2)
Layoffs (26)
Legal (414)
Liver cancer (1)
Lung cancer (29)
Lymphoma (23)
Machine learning (1)
Manufacturing (37)
MASH (16)
Medical device (307)
Medtech (310)
Mergers & acquisitions (1484)
Metabolic disorders (83)
Multiple sclerosis (13)
NASH (5)
Neurodegenerative disease (28)
Neuropsychiatric disorders (4)
Neuroscience (221)
NextGen: Class of 2026 (154)
Non-profit (71)
Obesity (40)
Opinion (8)
Ovarian cancer (13)
Pain (9)
Pancreatic cancer (9)
Parkinson's disease (11)
Patents (26)
Patient recruitment (14)
Peanut (1)
People (1992)
Phase 1 (1214)
Phase 2 (1937)
Phase 3 (1695)
Pipeline (710)
Policy (1)
Postmarket research (82)
Preclinical (336)
Prostate cancer (10)
Psychedelics (7)
Radiopharmaceuticals (21)
Rare diseases (74)
Real estate (110)
Regulatory (919)
Reports (3)
Research institute (103)
RNA editing (1)
RSV (8)
Schizophrenia (17)
Series A (11)
Series B (14)
Sickle cell disease (9)
Spinal muscular atrophy (20)
Sponsored (1)
Startups (167)
Stomach cancer (2)
Supply chain (4)
The Weekly (1)
Vaccines (64)
Venture capital (3)
Weight loss (22)
Women's health (1)
Date
Last 7 days (29)
Last 30 days (118)
Last 365 days (2058)
2026 (171)
2025 (2062)
2024 (2227)
2023 (2650)
2022 (2842)
2021 (3107)
2020 (2873)
2019 (1979)
2018 (1701)
2017 (1912)
2016 (1574)
2015 (2016)
2014 (1467)
2013 (1094)
2012 (1148)
2011 (1292)
2010 (1254)
Location
Africa (21)
Alabama (2)
Arizona (8)
Asia (2722)
Australia (591)
California (742)
Canada (256)
China (114)
Colorado (11)
Connecticut (28)
Delaware (33)
Europe (8471)
Florida (117)
Georgia (33)
Illinois (45)
India (2)
Indiana (12)
Japan (45)
Kansas (3)
Louisiana (1)
Maryland (77)
Massachusetts (558)
Michigan (6)
Minnesota (17)
Montana (1)
Nevada (2)
New Hampshire (3)
New Jersey (132)
New York (146)
North Carolina (72)
North Dakota (1)
Northern California (381)
Ohio (14)
Oregon (1)
Pennsylvania (110)
Rhode Island (1)
South America (40)
South Carolina (7)
Southern California (271)
Tennessee (2)
Texas (58)
United States (2223)
Utah (15)
Virginia (6)
Washington D.C. (2)
Washington State (29)
Wisconsin (1)
37,092 Results for "royal dsm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia
November 6, 2025
·
5 min read
Press Releases
IGC Pharma Expands CALMA Phase 2 Trial to Island Health’s Royal Jubilee Hospital in Canada
September 3, 2025
·
4 min read
Press Releases
Alveo Technologies and Royal GD To Expand Poultry Testing Portfolio Beyond Avian Influenza
July 25, 2025
·
5 min read
Press Releases
Peijia Medical collaborates with dsm-firmenich to create groundbreaking innovative medical device products
April 1, 2025
·
4 min read
dsm-firmenich and Zerion Pharma form a partnership to develop improved cannabinoids
Zerion Pharma A/S (“ZERION”) today announces an exclusive partnership with dsm-firmenich to take advantage of ZERION’s expertise and its Dispersome®
February 15, 2024
·
2 min read
DSM-5 Panel Members Received $14.2M in Industry Funding: Study
A new study published in the BMJ found strong financial ties between the pharmaceutical industry and physicians serving as panelists and task force members of the DSM-5.
January 11, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Xcell Biosciences and Royal Perth Hospital to Develop Next Gen Automated TIL Manufacturing Workflow
March 19, 2025
·
3 min read
Pharm Country
DSM comments on a new study linking COVID-19 to increased risk of neurological disorders - Omega 3s to be a potential solution
Royal DSM, a global science-based company active in Health, Nutrition and Bioscience, comments on the findings from a recently published paper in Nature Medicine which reported that those infected with COVID-19 are at increased risk of long-term neurologic disorders that persist post infection.
November 29, 2022
·
4 min read
Business
Oblique Therapeutics and the KTH Royal Institute of Technology (KTH) have entered into a strategic collaboration to analyse protein structures using supercomputers
Oblique Therapeutics, a leading biotechnology company specialising in the development of new drug candidates, is pleased to announce today that they have entered into an agreement with the KTH Royal Institute of Technology to utilise KTH’s state-of-the-art supercomputer resources for analysing protein structures.
June 18, 2024
·
3 min read
Business
Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept® S DSM 50 μm
Sirtex Medical (“Sirtex”) announced today the establishment of a collaboration and exclusive worldwide distribution agreement with Magle Group, a Sweden-based contract development and manufacturing organization as well as Degradable Starch Microspheres (DSM) sales and marketing company.
September 8, 2023
·
2 min read
1 of 3,710
Next
